Table Graph
      published meta-analysis   sensitivity analysis   studies

convalescent plasma treatment in COVID 19 all comers - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsLIFESAVER, 2021 2.00 [0.16; 24.66] 2.00[0.16; 24.66]LIFESAVER, 202110%12NAnot evaluable deathsdetailed resultsLIFESAVER, 2021 2.00 [0.16; 24.66] 2.00[0.16; 24.66]LIFESAVER, 202110%12NAnot evaluable0.55.01.0relative treatment effectwww.metaEvidence.org2024-04-19 08:08 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 94 - treatments: 538,957 - roots T: 290

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons